Theravance Biopharma (TBPH) Share-based Compensation Growth (5y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Theravance Biopharma | 823.54 Mn | 428.87 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -22.23% |
| Dec 31, 2025 | -22.03% |
| Sep 30, 2025 | -21.72% |
| Jun 30, 2025 | -22.82% |
| Mar 31, 2025 | -20.42% |
| Dec 31, 2024 | -24.60% |
| Sep 30, 2024 | -17.54% |
| Jun 30, 2024 | -13.80% |
| Mar 31, 2024 | -15.61% |
| Dec 31, 2023 | -13.04% |
| Sep 30, 2023 | -11.82% |
| Jun 30, 2023 | -14.68% |
| Mar 31, 2023 | -12.89% |
| Dec 31, 2022 | -17.14% |
| Sep 30, 2022 | -4.41% |
| Jun 30, 2022 | -1.36% |
| Mar 31, 2022 | 7.21% |
| Dec 31, 2021 | 11.00% |
| Sep 30, 2021 | 7.75% |
| Jun 30, 2021 | 8.57% |
| Mar 31, 2021 | 6.92% |
| Dec 31, 2020 | 6.20% |
| Sep 30, 2020 | 4.90% |
| Jun 30, 2020 | 2.50% |
| Mar 31, 2020 | -0.45% |
| Dec 31, 2019 | 10.64% |
| Sep 30, 2019 | 6.84% |
| Jun 30, 2019 | 10.81% |
| Mar 31, 2019 | -0.77% |
| Dec 31, 2018 | 17.82% |
| Sep 30, 2018 | 15.99% |
| Jun 30, 2018 | 17.42% |
| Mar 31, 2018 | 20.47% |